Trials / Completed
CompletedNCT02884609
Tolerance and Efficiency of Paracetamol Subcutaneous Injection
Tolerance and Efficiency of Paracetamol bu Subcutaneous Releasing in Patients Hospitalized Into Palliative Care
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (actual)
- Sponsor
- Centre Hospitalier Régional Metz-Thionville · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the tolerance and the efficiency of subcutaneous administration of Paracetamol for patients in palliative care.
Detailed description
Subcutaneous administration is the most commonly used way for palliative care and geriatric service. A lot of drugs are recommended with subcutaneous administration, but their use is performed out of the Marketing Authorization, and fewer data exist about this practice in literature. Paracetamol is a grade 1 analgesic not currently recommended for subcutaneous injection, because of the lack of validated references. However this kind of administration is usually performed for Paracetamol in the French palliative care services related with its advantages for patients, as analgesic or antipyretic. The assumption of the study is that the use of paracetamol subcutaneously is possible with a good tolerance for hospitalized patients in palliative care service.
Conditions
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2016-08-31
- Last updated
- 2019-04-16
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02884609. Inclusion in this directory is not an endorsement.